Global Patient Blood Management Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 15.12 Billion |
 Market Size (Forecast Year) |
USD 27.57 Billion |
 CAGR |
% |
| Major Markets Players |
>全球患者血液管理市场，按单位（血液成分、全血）、物品（仪器、血液处理设备、输血设备、血液培养筛查设备、诊断和检测仪器、血液储存设备、配件、注射器和针头、小瓶和试管、血库和输血软件、软件、检测试剂盒、载玻片染色、血型试剂、培养基、试剂和试剂盒、血袋）、最终用户（医院、血库）划分 - 行业趋势和预测至 2029 年
患者血液管理市场分析和规模
更好的管理可使患者通常需要输注更少的捐献血液成分，从而防止输血相关的并发症。患者血液管理指南的制定由国家血液管理局资助和监督。患者血液管理通过以支持和保护患者自身血液的方式增强患者的医疗和外科护理，从而改善患者的治疗效果。
Data Bridge Market Research 分析，患者血液管理市场规模在 2021 年为 120.7 亿美元，到 2029 年将飙升至 220.1 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 7.80%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
患者血液管理市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
单位（血液成分、全血）、物品（仪器、血液处理设备、输血设备、血培养筛查设备、诊断和检测仪器、血液储存设备、配件、注射器和针头、小瓶和试管、血库和输血软件、软件、检测试剂盒、载玻片染色、血型试剂、培养基、试剂和试剂盒、血袋）、最终用户（医院、血库） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Immucor, Inc. (U.S.), B Barun Melsungen AG (Germany), Maco Pharma (France), bioMérieux (France), KANEKA CORPORATION (Japan), Bio-Rad Laboratories Inc. (U.S.), Abbott (U.S.), Grifols, S.A. (Spain), F. Hoffmann-La Roche Ltd (Switzerland), LivaNova PLC (U.K.) |
|
Market Opportunities |
|
Market Definition
In order to preserve haemoglobin concentration, maximise hemostasis, and reduce blood loss, patient blood management (PBM) is the timely use of evidence-based medical and surgical ideas.
Patient Blood Management Market Dynamics
Drivers
- Increasing healthcare infrastructure
The patient blood management market is expected to experience dimensional growth from 2022 to 2029 due to the increased support for the value of donated blood from the various verticals of healthcare infrastructure, life sciences, placenta research, and haemoglobin for the advancement of the medical industry.
- Rise in number of blood donors
The number of blood donors is increasing, and lucrative aid is being offered in exchange for donating blood. Due to the real-time solution offered, within this succession, the patient blood management market has moved toward the upside on the success graph due to the rapid increase of awareness given by mushrooming blood donation camps.
- Technological developments
Accelerating pervasiveness of target viruses and forthcoming technological amendments is giving the optimum thrust in the market growth of the patient blood management market.
Opportunities
The possibility for market expansion will come from consumer familiarity with safe and secure blood donation transmission and usage and from market penetration in emerging markets.
Restraints/Challenges
Patient blood management businesses are subject to several restrictions during periods of rapid market growth, including costs associated with acquiring automated patient blood management systems and the potential for data loss. These concerns can limit the market's progress.
This patient blood management market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the patient blood management market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Patient Blood Management Market
新冠疫情对公司销售造成冲击。新冠疫情导致的封锁推迟了人们接受健康检查的时间，减少了检测数量和试剂销售。不过，随着各国政府逐步放宽旅行限制，检测数量正在增加。自新冠疫情爆发以来，应对传染病已成为全球主要问题。除了疫苗和治疗药物外，对更精确、更简单的检测技术的需求也在增长，检测体系的扩展也同样如此。
全球患者血液管理市场范围
患者血液管理市场按物品、单位和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
单元
- 血液成分
- 全血
文章
- 仪器
- 血液处理设备
- 输血设备
- 血培养筛查设备
- 诊断和测试仪器
- 血液储存设备
- 配件
- 注射器和针头
- 药瓶和试管
- 血库和输血软件
- 软件
- 检测试剂盒
- 载玻片染色
- 血型鉴定试剂
- 文化传媒
- 试剂和试剂盒
- 血袋
最终用户
- 医院
- 血库
患者血液管理市场区域分析/见解
对患者血液管理市场进行了分析，并按国家、文章、单位和最终用户提供了市场规模洞察和趋势，如上所述。
患者血液管理市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于卓越的医疗保健基础设施，北美在患者血液管理市场中占据主导地位。
由于各成熟市场参与者都致力于扩大其在该特定地区的影响力并鼓励还款规范，预计亚太地区将在 2022 年至 2029 年的预测期内实现最高增长率。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和患者血液管理市场份额分析
患者血液管理市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对患者血液管理市场的关注有关。
患者血液管理市场的一些主要参与者包括：
- Haemonetics 公司 (美国)
- Fresenius SE & Co. KGaA（德国）
- 泰尔茂株式会社 (日本)
- Immucor, Inc.（美国）
- B Barun Melsungen AG（德国）
- Maco Pharma（法国）
- 生物梅里埃（法国）
- KANEKA株式会社（日本）
- Bio-Rad Laboratories Inc.（美国）
- 雅培（美国）
- Grifols, SA（西班牙）
- F. Hoffmann-La Roche Ltd（瑞士）
- LivaNova PLC（英国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
